CT 327 in the Treatment of Atopic Dermatitis

Summary

This study will look at how safe and effective, a novel agent, CT 327 cream is in treating patients with mild to moderate atopic dermatitis (AD). Patients will be treated twice daily for 14 days on specific lesions of AD and safety and symptoms of AD will be assessed throughout the treatment period.

Timeline

Start

2009-11

Primary completion

2010-10

Completion

2010-10

Drugs

Indications